SuperworthTransMedics price to free cash flow TMDX
Market value divided by free cash flow over the last twelve months, since 2025.
- Today, Oct 23, 2026
- 31.0×
- Peer median
- 21.2×
TransMedics' price to free cash flow is 31.0× as of Oct 23, 2026.
The median for 4 medical device stocks of a similar size is 21.2×.
Price to free cash flow over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 31.0× | 14.4× | 41.6× |
| 2025 | 35.2× | 32.6× | 256× |
Against its peers
Companies in Medical - Devices nearest TransMedics' size, closest first, today.
| Company | Price to free cash flow |
|---|---|
| TMDXTransMedics | 31.0× |
| CNMDCONMED | 11.0× |
| ITGRInteger | 38.4× |
| LIVNLivaNova | 30.1× |
| ZBHZimmer Biomet | 12.3× |
| Peer median | 21.2× |
What the price to free cash flow tells you
Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.
Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.
More on TransMedics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.